{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:25:19Z","timestamp":1794029119848,"version":"4.8.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460272"],"award-info":[{"award-number":["82460272"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017957","name":"Health Commission of Guizhou Province","doi-asserted-by":"publisher","award":["gzwkj2026-162"],"award-info":[{"award-number":["gzwkj2026-162"]}],"id":[{"id":"10.13039\/100017957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","award":["[2024]fy007"],"award-info":[{"award-number":["[2024]fy007"]}],"id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","award":["gyfyxkrc-2023\\u201305"],"award-info":[{"award-number":["gyfyxkrc-2023\\u201305"]}],"id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","award":["gyfybsky-2026-03"],"award-info":[{"award-number":["gyfybsky-2026-03"]}],"id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.neuropharm.2026.111206","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:44:37Z","timestamp":1791182677000},"page":"111206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SV2A attenuates interictal anxiety in pharmacoresistant epilepsy via the SYT3\u2013GluA2 axis"],"prefix":"10.1016","volume":"302","author":[{"given":"Chen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7345-3404","authenticated-orcid":false,"given":"Tianchuan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mianmian","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0517-4723","authenticated-orcid":false,"given":"Likun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111206_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116766","article-title":"Evaluation of potential anticonvulsant fluorinated N-benzamide enaminones as T-type Ca(2+) channel blockers","volume":"65","author":"Amaye","year":"2022","journal-title":"Bioorg. Med. Chem."},{"issue":"6422","key":"10.1016\/j.neuropharm.2026.111206_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav1483","article-title":"Synaptotagmin-3 drives AMPA receptor endocytosis, depression of synapse strength, and forgetting","volume":"363","author":"Awasthi","year":"2019","journal-title":"Science"},{"issue":"6422","key":"10.1016\/j.neuropharm.2026.111206_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav1483","article-title":"Synaptotagmin-3 drives AMPA receptor endocytosis, depression of synapse strength, and forgetting","volume":"363","author":"Awasthi","year":"2019","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111206_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.tibs.2004.01.008","article-title":"The C2 domains of synaptotagmin--partners in exocytosis","volume":"29","author":"Bai","year":"2004","journal-title":"Trends Biochem. Sci."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111206_bib5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1091\/mbc.E17-11-0623","article-title":"The synaptotagmin C2B domain calcium-binding loops modulate the rate of fusion pore expansion","volume":"29","author":"Bendahmane","year":"2018","journal-title":"Mol. Biol. Cell"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111206_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.yebeh.2009.12.009","article-title":"Prevalence of anxiety disorders in patients with refractory focal epilepsy--a prospective clinic based survey","volume":"17","author":"Brandt","year":"2010","journal-title":"Epilepsy Behav."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111206_bib7","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s11011-021-00719-2","article-title":"The functions of repressor element 1-silencing transcription factor in models of epileptogenesis and post-ischemia","volume":"36","author":"Butler-Ryan","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111206_bib8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/ijms25010111","article-title":"Molecular mechanisms of AMPA receptor trafficking in the nervous system","volume":"25","author":"Cao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111206_bib9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/jamaneurol.2025.5625","article-title":"Comparative effectiveness of brivaracetam, cenobamate, lacosamide, and perampanel in focal epilepsy","volume":"83","author":"Cerulli Irelli","year":"2026","journal-title":"JAMA Neurol."},{"issue":"26","key":"10.1016\/j.neuropharm.2026.111206_bib10","doi-asserted-by":"crossref","first-page":"15268","DOI":"10.1073\/pnas.96.26.15268","article-title":"Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)","volume":"96","author":"Crowder","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111206_bib11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.yebeh.2012.09.026","article-title":"Psychiatric comorbidity in refractory focal epilepsy: a study of 490 patients","volume":"25","author":"Dalmagro","year":"2012","journal-title":"Epilepsy Behav."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111206_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e14522","article-title":"Comparative analysis between open field and elevated plus Maze tests as a method for evaluating anxiety-like behavior in mice","volume":"9","author":"Figueiredo Cerqueira","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.neuropharm.2026.111206_bib13","article-title":"Calcium Permeable-AMPA receptors and excitotoxicity in neurological disorders","volume":"15","author":"Guo","year":"2021","journal-title":"Front. Neural Circ."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111206_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrn.2016.37","article-title":"Synaptic AMPA receptor composition in development, plasticity and disease","volume":"17","author":"Henley","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111206_bib15","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/j.1528-1167.2009.02185.x","article-title":"Economic burden of epilepsy in a developing country: a retrospective cost analysis in China","volume":"50","author":"Hong","year":"2009","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111206_bib16","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/hipo.22761","article-title":"The calcium sensor synaptotagmin 1 is expressed and regulated in hippocampal postsynaptic spines","volume":"27","author":"Hussain","year":"2017","journal-title":"Hippocampus"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111206_bib17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/can.2022.0078","article-title":"Effects of Delta(9)-THC and Type-1 cannabinoid receptor agonists in the elevated plus maze test of anxiety: a systematic review and meta-analysis","volume":"8","author":"Iglesias","year":"2023","journal-title":"Cannabis Cannabinoid Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111206_bib18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.expneurol.2007.09.026","article-title":"Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation","volume":"209","author":"Jones","year":"2008","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111206_bib19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/mp.2011.56","article-title":"Accounting for comorbidity in assessing the burden of epilepsy among US adults: results from the National Comorbidity Survey Replication (NCS-R)","volume":"17","author":"Kessler","year":"2012","journal-title":"Mol. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111206_bib20","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111206_bib21","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/cercor\/bhl041","article-title":"Emotion induction after direct intracerebral stimulations of human amygdala","volume":"17","author":"Lanteaume","year":"2007","journal-title":"Cerebr. Cortex"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111206_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14778","article-title":"Synaptic vesicle protein 2A mitigates parthanatos via apoptosis-inducing factor in a rat model of pharmacoresistant epilepsy","volume":"30","author":"Li","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111206_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112233","article-title":"Synaptotagmin-3 interactions with GluA2 mediate brain damage and impair functional recovery in stroke","volume":"42","author":"Lu","year":"2023","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111206_bib23","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1523\/JNEUROSCI.2594-13.2014","article-title":"Interactions between N-ethylmaleimide-sensitive factor and GluR2 in the nucleus accumbens contribute to the expression of locomotor sensitization to cocaine","volume":"34","author":"Lu","year":"2014","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111206_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70366","article-title":"Effects of electroacupuncture on Syt3 and GluA2 in rats with limb spasms after intracerebral hemorrhage","volume":"15","author":"Lu","year":"2025","journal-title":"Brain Behav."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111206_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.eplepsyres.2007.08.005","article-title":"Changes in depression, anxiety, anger, and personality after resective surgery for drug-resistant temporal lobe epilepsy: a 2-year follow-up study","volume":"77","author":"Meldolesi","year":"2007","journal-title":"Epilepsy Res."},{"issue":"16","key":"10.1016\/j.neuropharm.2026.111206_bib27","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1212\/WNL.0b013e3182a393d1","article-title":"Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the guideline development subcommittee of the American academy of neurology","volume":"81","author":"Morris","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2026.111206_bib28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.biopha.2018.10.141","article-title":"Extracellular calcium influx through L-type calcium channels, intracellular calcium currents and extracellular signal-regulated kinase signaling are involved in the abscisic acid-induced precognitive and anti-anxiety effects","volume":"109","author":"Naderi","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2026.111206_bib29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.neubiorev.2021.05.005","article-title":"Anxiety and Alzheimer's disease: behavioral analysis and neural basis in rodent models of alzheimer's-related neuropathology","volume":"127","author":"Pentkowski","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"14","key":"10.1016\/j.neuropharm.2026.111206_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147568","article-title":"Morphological and functional alterations in the CA1 pyramidal neurons of the Rat Hippocampus in the chronic phase of the lithium-pilocarpine model of epilepsy","volume":"25","author":"Postnikova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111206_bib31","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1528-1167.2012.03500.x","article-title":"Epilepsy and psychiatric comorbidity: a nationally representative population-based study","volume":"53","author":"Rai","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2026.111206_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104928","article-title":"Reliability of common mouse behavioural tests of anxiety: a systematic review and meta-analysis on the effects of anxiolytics","volume":"143","author":"Rosso","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"21","key":"10.1016\/j.neuropharm.2026.111206_bib33","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1523\/JNEUROSCI.2875-12.2016","article-title":"Nucleus accumbens AMPA receptors are necessary for morphine-withdrawal-induced negative-affective states in rats","volume":"36","author":"Russell","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111206_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105378","article-title":"Differential effects of levetiracetam on hippocampal CA1 synaptic plasticity and molecular changes in the dentate gyrus in epileptic rats","volume":"158","author":"Salaka","year":"2022","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2026.111206_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111536","article-title":"Synaptic vesicle protein 2A regulates mossy fiber sprouting in a drug-resistant epilepsy rat model via laminin alpha5\/integrin beta1","volume":"231","author":"Shi","year":"2025","journal-title":"Brain Res. Bull."},{"issue":"6061","key":"10.1016\/j.neuropharm.2026.111206_bib36","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.1210125","article-title":"Entorhinal cortex layer III input to the hippocampus is crucial for temporal association memory","volume":"334","author":"Suh","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.111206_bib37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fphar.2016.00210","article-title":"A missense mutation of the gene encoding synaptic vesicle glycoprotein 2A (SV2A) confers seizure susceptibility by disrupting amygdalar synaptic GABA release","volume":"7","author":"Tokudome","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111206_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/srep27420","article-title":"Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission","volume":"6","author":"Tokudome","year":"2016","journal-title":"Sci. Rep."},{"issue":"20","key":"10.1016\/j.neuropharm.2026.111206_bib39","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.1021\/bi010340c","article-title":"The C2B domain of synaptotagmin I is a Ca2+-binding module","volume":"40","author":"Ubach","year":"2001","journal-title":"Biochemistry"},{"issue":"14","key":"10.1016\/j.neuropharm.2026.111206_bib40","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.3390\/jcm13144114","article-title":"Evaluating the efficacy of vagus nerve stimulation across 'Minor' and 'Major' seizure types: a retrospective analysis of clinical outcomes in pharmacoresistant epilepsy","volume":"13","author":"Urian","year":"2024","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111206_bib41","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jnr.23111","article-title":"Altered balance between excitatory and inhibitory inputs onto CA1 pyramidal neurons from SV2A-deficient but not SV2B-deficient mice","volume":"90","author":"Venkatesan","year":"2012","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111206_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s42494-025-00219-1","article-title":"Cost-effectiveness analysis of vagus nerve stimulation in drug-resistant epilepsy","volume":"7","author":"Xiong","year":"2025","journal-title":"Acta Epileptol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111206_bib43","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1038\/s41467-024-47322-4","article-title":"Structural basis for antiepileptic drugs and botulinum neurotoxin recognition of SV2A","volume":"15","author":"Yamagata","year":"2024","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.neuropharm.2026.111206_bib44","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1111\/jcmm.17986","article-title":"Effect of intranasal and oral administration of levetiracetam on the temporal and spatial distributions of SV2A in the KA-induced rat model of SE","volume":"27","author":"Zhao","year":"2023","journal-title":"J. Cell Mol. Med."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111206_bib45","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1007\/s12035-017-0571-x","article-title":"Adenosine A1 receptors play an important protective role against cognitive impairment and long-term potentiation inhibition in a pentylenetetrazol mouse model of epilepsy","volume":"55","author":"Zhou","year":"2018","journal-title":"Mol. Neurobiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:54:24Z","timestamp":1794027264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":45,"alternative-id":["S0028390826003813"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111206","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SV2A attenuates interictal anxiety in pharmacoresistant epilepsy via the SYT3\u2013GluA2 axis","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111206"}}